DionisiaMarieQuirogaDOPh.D(She/Her)

PubMed

• Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase.
  Savardekar, H., Allen, C., Jeon, H., Li, J., Quiroga, D., Schwarz, E., Wu, R., Zelinskas, S., Lapurga, G., Abreo, A., Stiff, A., Shaffer, J., Blaser, B., Old, M., Weso...> ;Molecular Cancer Research. 2024 Mar 1
• Searching Beyond Programmed Cell Death Ligand 1 in Metastatic Breast Cancer-Still Haven't Found What We're Looking For.
  Quiroga, D., Gatti-Mays, M.> ;JAMA Oncology. 2024 Feb 1
• A cancer disparities curriculum in a hematology/oncology fellowship program.
  Marium Husain, Muhammad Salman Faisal, Dionisia Quiroga, Audrey M Sigmund, Gregory Otterson, Alison Walker, Samilia Obeng-Gyasi, Beth Christian> ;BMC Medical Education. 2023 Oct 17
• The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
  Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Abdul Miah, Craig Vargo, Michael Berger, Preeti Sudheendr...> ;Oncology and Therapy. 2023 Sep 1
• Where the Sidewalk Ends: Parenting as a Trainee during COVID-19.
  Mazie Tsang, Rahul Banerjee, Dionisia Quiroga, Dame Idossa, Kelly L Schoenbeck> ;Cancer Investigation. 2023 Jul 1
• 4 citations
  Clinical markers of immunotherapy outcomes in advanced sarcoma.
  Marium Husain, Dionisia Quiroga, Han Gil Kim, Scott Lenobel, Menglin Xu, Hans Iwenofu, James L Chen, Claire Verschraegen, David Liebner, Gabriel Tinoco> ;BMC Cancer. 2023 Apr 7
• Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
  Williams, N., Quiroga, D., Johnson, C., Brufsky, A., Chambers, M., Bhattacharya, S., Patterson, M., Sardesai, S., Stover, D., Lustberg, M., Noonan, A., Cherian, M., By...> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
• 1 citations
  Treatment of small (T1mic, T1a, and T1b) node-negative HER2+ breast cancer - a review of current evidence for and against the use of anti-HER2 treatment regimens.
  Kai Cc Johnson, Dionisia Quiroga, Preeti Sudheendra, Robert Wesolowski> ;Expert Review of Anticancer Therapy. 2022 May 1
• Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breast.
  Alecia Blaszczak, Dionisia Quiroga, Anahita Jalilvand, Gina S. Torres Matias, Valerie P. Wright, Joey Liu, Lianbo Yu, David Bradley, Willa A. Hsueh, William E. Carson> ;Surgical Oncology. 2021 Sep 9
• 4 citations
  Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer
  Jasmine Sukumar, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Namrata Vilas Shinde, Leslie Appiah, Marilly Palettas, Julie A. Stephens, Margaret E Gatti-Mays, Ashl...> ;Breast Cancer Research and Treatment. 2021 Sep 8
• 70 citations
  Triple-negative breast cancer: promising prognostic biomarkers currently in development.
  Jasmine Sukumar, Kelly Gast, Dionisia Quiroga, Maryam B. Lustberg, Nicole Williams> ;Expert Review of Anticancer Therapy. 2021 Feb 1
• 15 citations
  Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
  Dionisia Quiroga, David A. Liebner, Jennifer Philippon, Sarah Hoffman, Yubo Tan, James L. Chen, Scott Lenobel, Paul E. Wakely, Raphael E. Pollock, Gabriel Tinoco> ;BMC Cancer. 2020 Jun 5
• 12 citations
  Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable b...
  Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, Christopher McQuinn, Zaibo Li, Hiroaki Nitta, Himanshu Savardekar, Brooke Benner, Bhuvaneswari Ramaswamy, Maryam B. ...> ;BMC Cancer. 2020 May 19
• 78 citations
  Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
  Brooke Benner, Logan Good, Dionisia Quiroga, Thomas E Schultz, Mahmoud Kassem, William E. Carson, Mathew Cherian, Sagar Sardesai, Robert Wesolowski> ;Drug Design, Development and Therapy. 2020 May 4
• 1 citations
  Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses.
  Dionisia Quiroga, Yasser A. Aldhamen, Sarah Godbehere, Laura Harding, Andrea Amalfitano> ;Clinical and Vaccine Immunology. 2017 Jun 1
• 3 citations
  Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.
  Elizabeth L. McMichael, Courtney Nb, Megan C. Duggan, Robert Wesolowski, Dionisia Quiroga, Sri Vidya Kondadasula, Atwal Ls, Neela Bhave, Eric Luedke, Alena Cristina Ja...> ;Oncoimmunology. 2017 May 2
• 31 citations
  Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
  Dionisia Quiroga, H. Kim Lyerly, Michael A. Morse> ;Current Treatment Options in Oncology. 2016 Jun 17
• 3 citations
  Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination
  Dionisia Quiroga, Yasser A. Aldhamen, Daniel M. Appledorn, Sarah Godbehere, Andrea Amalfitano> ;Cancer Immunology, Immunotherapy. 2015 Feb 6
• 36 citations
  Autoimmune Disease-Associated Variants of Extracellular Endoplasmic Reticulum Aminopeptidase 1 Induce Altered Innate Immune Responses by Human Immune Cells
  Yasser A. Aldhamen, Yuliya Pepelyayeva, David P W Rastall, Sergey S. Seregin, Efthalia Zervoudi, Despoina Koumantou, Charles F. Aylsworth, Dionisia Quiroga, Sarah Godb...> ;Journal of Innate Immunity. 2015 Jan 14
• 50 citations
  Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.
  Sergey S. Seregin, David P W Rastall, Irini Evnouchidou, Charles F. Aylsworth, Dionisia Quiroga, Ram P. Kamal, Sarah Godbehere-Roosa, Christopher F. Blum, Ian A. York,...> ;Autoimmunity. 2013 Nov 4
• 11 citations
  TRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivo.
  Sergey S. Seregin, Yasser A. Aldhamen, Daniel M. Appledorn, Charles F. Aylsworth, Sarah Godbehere, Chyong Jy Joyce Liu, Dionisia Quiroga, Andrea Amalfitano> ;Plos One. 2011 Jul 8
• 30 citations
  A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target
  Daniel M. Appledorn, Yasser A. Aldhamen, William H. DePas, Sergey S. Seregin, Chyong Jy J Liu, Nathaniel J. Schuldt, Darin Quach, Dionisia Quiroga, Sarah Godbehere, Ig...> ;Plos One. 2010 Mar 8
• Join now to see all